Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N6OL
|
||||
Former ID |
DNC006945
|
||||
Drug Name |
ADS-103253
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528581] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H21ClN4O2
|
||||
Canonical SMILES |
CC1=NC(=NC2=C1C=C(C=C2)NC(=O)COC3=CC=C(C=C3)Cl)N4CCCC4
|
||||
InChI |
1S/C21H21ClN4O2/c1-14-18-12-16(24-20(27)13-28-17-7-4-15(22)5-8-17)6-9-19(18)25-21(23-14)26-10-2-3-11-26/h4-9,12H,2-3,10-11,13H2,1H3,(H,24,27)
|
||||
InChIKey |
MXDQNCXNQJMIEH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Melanin-concentrating hormone receptor 1 | Target Info | Inhibitor | [528581] | |
Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [528581] | ||
5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [528581] | ||
PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP706:SIDS Susceptibility Pathways | |||||
Hematopoietic Stem Cell Differentiation | |||||
Potassium ChannelsWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
Monoamine GPCRs | |||||
GPCR downstream signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.